Last reviewed · How we verify

GSK2336805 120 mg

Janssen R&D Ireland · Phase 1 active Small molecule Quality 0/100

At a glance

Generic nameGSK2336805 120 mg
SponsorJanssen R&D Ireland
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results